Catamaran SI Joint Fusion System
Commercial- Indications
- Sacroiliac joint pain, Sacroiliac joint disruptions, Degenerative sacroiliitis
Company intelligence / Profile preview
The Catamaran SI Joint Fusion System has demonstrated strong clinical results in the MAINSAIL study. At 6 months post-procedure, 80% of patients met the composite success endpoint (≥20mm reduction in pain VAS score; no serious device-related adverse events; no neurological worsening; no reintervention). There was a significant reduction in pain scores and improvement in function. No serious adverse events or reoperations were reported. Patient satisfaction at 6 months was high at 93.3%. At 12 months, radiographic evidence of fusion was observed in most evaluated patients.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tenon Medical.